City

Duarte (1)

Houston (1)

Palo Alto (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

phase 1 (2)

Sponsor

City of Hope Medical Center (1)

M.D. Anderson Cancer Center (1)

Stanford University (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

acetaminophen (1)

dexamethasone (1)

diphenhydramine (1)

flotetuzumab (1)

fructooligosaccharide (1)

ibuprofen (1)

laboratory biomarker analysis (1)

ranitidine (1)

survey administration (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

recurrent hematologic malignancy

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Distress Associated With Coronavirus Disease 2019 and Telehealth

Active, not recruiting

Advanced Malignant Solid Neoplasm
+6 more

Survey Administration

Houston, Texas

M D Anderson Cancer Center

Jun 27, 2022

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting

Recurrent Acute Leukemia
+16 more

Acetaminophen
+5 more

Duarte, California

City of Hope Medical Center

Nov 1, 2021

Hematopoietic and Lymphoid Cell Tumor, Recurrent Hematologic Malignancy Trial in Palo Alto (Fructooligosaccharide, Laboratory

Completed

Hematopoietic and Lymphoid Cell Neoplasm
Recurrent Hematologic Malignancy

Fructooligosaccharide
Laboratory Biomarker Analysis

Palo Alto, California

Stanford University, School of Medicine

Mar 18, 2021